Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants with Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1)
Sponsored by Bristol-Myers Squibb
Active
$277.3K Funding
5 People
External
Related Topics
clinical trials,
autoimmune diseases,
medication efficacy,
safety assessment,
immunology
People
C. Kent Kwoh
Principal Investigator (PI)
Medicine
﹒Professor
Gina Schwartzberg
(CD)
College of Medicine - Tucson
﹒Research Program Administration Manager II
Jazmin Dagnino
(CD)
College of Medicine - Tucson
﹒Clinical Research Coordinator III
Kirsten Anderson
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator IV
Gustavo Cornejo
(CD)
Az Health Sciences Division
﹒Research Compliance Administrator III
